Acadia Pharmaceuticals buy Morgan Stanley
Start price
19.12.23
/
50%
€27.40
Target price
19.12.24
€36.48
Performance (%)
-41.15%
End price
20.12.24
€16.13
Summary
This prediction ended on 20.12.24 with a price of €16.13. The BUY prediction by Morgan_Stanley for Acadia Pharmaceuticals performed very badly with a performance of -41.15%. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Acadia Pharmaceuticals | -0.284% | -0.284% | 12.936% |
| iShares Core DAX® | 0,63 % | 4,95 % | 8,66 % |
| iShares Nasdaq 100 | 1,16 % | -1,16 % | 26,82 % |
| iShares Nikkei 225® | 2,36 % | -1,35 % | 48,19 % |
| iShares S&P 500 | 0,63 % | 1,38 % | 22,99 % |
Comments by Morgan_Stanley for this prediction
In the thread Acadia Pharmaceuticals diskutieren
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) was upgraded by analysts at Morgan Stanley from an "equal weight" rating to an "overweight" rating. They now have a $40.00 price target on the stock, up previously from $31.00.
Ratings data for ACAD provided by MarketBeat
In the thread Trading Acadia Pharmaceuticals
Die von Morgan_Stanley gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Morgan_Stanley for Acadia Pharmaceuticals
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€16.27
12.07.24
12.07.24
€25.68
12.07.25
12.07.25
9.19%
13.07.25
13.07.25
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€17.30
18.03.24
18.03.24
€27.59
18.03.25
18.03.25
-8.24%
19.03.25
19.03.25